Diabetic kidney disease review mapped risk markers and treatment associations
Blood pressure, selected biomarkers and glucose control had some of the strongest evidence, but the review does not make every association causal.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review ranked evidence linking health conditions, biological markers, body measurements and treatments with diabetic kidney disease. High blood pressure and certain biomarkers were associated with greater risk, while intensive blood glucose control was associated with lower risk. These findings identify patterns in existing research; they do not make every marker a proven treatment target.
This is an abstract-based account of a review of earlier analyses. The abstract does not separate study designs for each association or give reference groups, limiting causal and treatment interpretation.
How evidence was ranked
The authors examined existing pooled research, checking consistency, study quality and potential biases. Their strongest evidence category included hypertension, selected tumor necrosis factor receptor measures, Helicobacter pylori infection and intensive blood glucose control.
A broad collection of associations
Other associations involved depression, waist measurements, eye complications of diabetes, vitamin D deficiency and medication use. These were not all given the same evidence rating, and the abstract does not specify comparison groups or follow-up periods.
The original publication
[Construction of evidence graph of modifiable risk factors for diabetic nephropathy].
Shi SY, Zhou QX, Sun F et al.
Zhonghua Liu Xing Bing Xue Za Zhi · 2025
- PubMed ID
- 41443722
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.